Page last updated: 2024-12-08

5-chloro-3-tert-butyl-2'-chloro-4'-nitrosalicylanilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID189036
CHEMBL ID4441011
SCHEMBL ID1727681
MeSH IDM0046503

Synonyms (9)

Synonym
s-13
16128-96-4
3-tert-butyl-5-chloro-n-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide
5-chloro-3-tert-butyl-2'-chloro-4'-nitrosalicylanilide
5-chloro-n-(2-chloro-4-nitrophenyl)-3-(1,1-dimethylethyl)-2-hydroxybenzamide
SCHEMBL1727681
DTXSID00167102
5-chloro-3-t-butyl-2'-chloro-4'-nitrosalicylanilide
CHEMBL4441011
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1512641Dissociation constant, pKa of compound2018Journal of medicinal chemistry, 06-14, Volume: 61, Issue:11
Small Molecule Mitochondrial Uncouplers and Their Therapeutic Potential.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]